Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burkhard Haefner

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cancer Treatment and Research|April 14, 2006
Targeting NF-kappaB in anticancer adjunctive chemotherapyBurkhard Haefner
Drug Discovery Today|June 25, 2003
Drugs from the deep: marine natural products as drug candidatesBurkhard Haefner
Drug Discovery Today|July 12, 2002
NF-kappa B: arresting a major culprit in cancerBurkhard Haefner
Drug News & Perspectives|January 1, 2004
Glycogen synthase kinase-3 as drug target: from wallflower to center of attentionJean Van Wauwe, Burkhard Haefner
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cancer Treatment and Research|April 14, 2006
Targeting NF-kappaB in anticancer adjunctive chemotherapyBurkhard Haefner
Drug Discovery Today|June 25, 2003
Drugs from the deep: marine natural products as drug candidatesBurkhard Haefner
Drug Discovery Today|July 12, 2002
NF-kappa B: arresting a major culprit in cancerBurkhard Haefner
Drug News & Perspectives|January 1, 2004
Glycogen synthase kinase-3 as drug target: from wallflower to center of attentionJean Van Wauwe, Burkhard Haefner
Pageof 1